Published in Br J Cancer on September 01, 1996
Biologic predictors of survival in node-negative gastric cancer. Ann Surg (2003) 1.37
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 1.21
Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer (2006) 1.08
Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol (2007) 0.97
Association of color Doppler vascularity index and microvessel density with survival in patients with gastric cancer. Ann Surg (2002) 0.96
Prognostic value of perineural invasion in gastric cancer: a systematic review and meta-analysis. PLoS One (2014) 0.90
Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma. Ann Surg (2001) 0.88
Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Br J Cancer (2001) 0.85
The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer (2015) 0.84
Advanced gastric cancer and perfusion imaging using a multidetector row computed tomography: correlation with prognostic determinants. Korean J Radiol (2008) 0.83
Assessment of vascular invasion in gastric cancer: a comparative study. World J Gastroenterol (2013) 0.82
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting. Hum Vaccin Immunother (2013) 0.80
Clinicopathological significance of MMP-7, laminin γ2 and EGFR expression at the invasive front of gastric carcinoma. Gastric Cancer (2013) 0.80
Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis. Contemp Oncol (Pozn) (2016) 0.80
Analysis of risk factors for the interval time, number and pattern of hepatic metastases from gastric cancer after radical gastrectomy. World J Gastroenterol (2008) 0.80
Expression of thymidylate synthase determines the response of gastric cancer patients undergoing gastrectomy to 5-fluorouracil-based adjuvant chemotherapy. Langenbecks Arch Surg (2009) 0.79
The Prognostic Significance of Her2-Neu Over expression in Gastric Carcinomas. Iran J Cancer Prev (2011) 0.76
Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer. BMC Cancer (2016) 0.75
Prognostic factors in gastric carcinoma. Br J Cancer (1997) 0.75
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand (1965) 22.65
Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet (1995) 7.64
Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol (1993) 5.37
Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg (1993) 3.45
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
Prognostic significance of histological type in gastric carcinoma with invasion confined to the stomach wall. Br J Surg (1993) 1.56
Does delay in fixation affect the number of mitotic figures in processed tissue? J Clin Pathol (1990) 1.38
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer (1992) 1.18
Blood vessel invasion in gastric carcinoma. Surgery (1990) 1.15
Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg (1993) 1.14
Incidence and prognostic significance of vascular invasion in 529 gastric-cancer patients. Int J Cancer (1991) 1.09
Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms. Pathol Res Pract (1989) 1.01
Perineural invasion as a predictor of recurrence of gastric cancer. Cancer (1994) 1.01
News of TNM and its use for classification of gastric cancer. World J Surg (1995) 0.99
Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol (1990) 0.99
Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer (1995) 0.98
Prognostic factors in stomach cancer surgery. Eur J Surg Oncol (1986) 0.91
Mitotic activity and prognosis in prostatic adenocarcinoma. Prostate (1995) 0.86
Cytophotometrically determined DNA content, mitotic activity, and lymph node metastasis in clinical gastric cancer. Surgery (1990) 0.86
Neural invasion in gastric carcinoma. J Clin Pathol (1995) 0.86
Human gastric carcinoma: prognosis in relation to macroscopic and microscopic features of the primary tumor. J Natl Cancer Inst (1983) 0.84
Mitotic indexes as prognostic predictors in female breast cancer. J Cancer Res Clin Oncol (1992) 0.83
Potential of nuclear morphometry and volume-corrected mitotic index in grading transitional cell carcinoma of the urinary bladder. Eur Urol (1990) 0.82
Radical surgery (R2 resection) for gastric cancer. A multivariate analysis. Scand J Gastroenterol (1994) 0.82
[Mitotic activity of cancer cells and survival of gastric cancer patients]. Nihon Geka Gakkai Zasshi (1986) 0.79
[Cytophotometrically determined DNA content, mitotic index and proliferative activity clinical gastric cancer]. Gan To Kagaku Ryoho (1995) 0.79
Morphological predictors of survival in early and advanced gastric carcinoma. J Cancer Res Clin Oncol (1992) 0.78
A comparison of diets with and without oats in adults with celiac disease. N Engl J Med (1995) 4.14
Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol (1997) 3.09
Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist (1995) 2.75
Carcinogenicity of the drinking water mutagen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone in the rat. J Natl Cancer Inst (1997) 2.38
Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol (2000) 1.93
Hypermethylation of the APC (adenomatous polyposis coli) gene promoter region in human colorectal carcinoma. Int J Cancer (1997) 1.82
High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer. Cancer Res (2000) 1.77
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer. Cancer Res (1998) 1.59
Diagnostic methods in dyspepsia: the usefulness of upper abdominal ultrasound and gastroscopy. Scand J Prim Health Care (1997) 1.50
Nutritional status of newly diagnosed celiac disease patients before and after the institution of a celiac disease diet--association with the grade of mucosal villous atrophy. Am J Clin Nutr (1998) 1.49
Comparative liver toxicity of various erythromycin derivatives in animals. J Antimicrob Chemother (1988) 1.41
Osteoporosis in adult patients with celiac disease. Bone (1999) 1.41
Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer (1994) 1.40
DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification. J Pathol (2007) 1.40
Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis (2001) 1.37
Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells. J Biol Chem (2001) 1.35
Monitoring of periprosthetic BMD after uncemented total hip arthroplasty with dual-energy X-ray absorptiometry--a 3-year follow-up study. J Bone Miner Res (2001) 1.28
Acute cholecystitis treated by early and delayed surgery. A controlled clinical trial. Scand J Gastroenterol (1978) 1.26
Laparoscopic or open cholecystectomy: a prospective randomised trial to compare postoperative pain, pulmonary function, and stress response. Eur J Surg (2000) 1.25
Enzyme replacement therapy in a mouse model of aspartylglycosaminuria. FASEB J (2000) 1.24
Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Arch Geschwulstforsch (1982) 1.24
Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV infections. J Oral Pathol Med (1992) 1.23
Polymorphic catechol-O-methyltransferase gene and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.23
Hyaluronan expression in gastric cancer cells is associated with local and nodal spread and reduced survival rate. Br J Cancer (1999) 1.21
Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut (2000) 1.20
Human papillomavirus lesions in association with cervical dysplasias and neoplasias. Obstet Gynecol (1983) 1.20
High stromal hyaluronan level is associated with poor differentiation and metastasis in prostate cancer. Eur J Cancer (2001) 1.18
Tumour infiltrating lymphocytes as an independent prognostic factor in transitional cell bladder cancer. Eur J Cancer (1992) 1.18
Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg (1983) 1.17
Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol (2006) 1.16
Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. J Clin Oncol (1998) 1.15
Mast cells in breast cancer. Anticancer Res (1993) 1.13
Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12
Cytologic evidence of the association of condylomatous lesions with dysplastic and neoplastic changes in the uterine cervix. Acta Cytol (1981) 1.12
Bone recovery after a gluten-free diet: a 5-year follow-up study. Bone (1999) 1.11
Human papillomavirus (HPV) infections of the female genital tract and their associations with intraepithelial neoplasia and squamous cell carcinoma. Pathol Annu (1986) 1.11
Exposure of an infant to cervical human papillomavirus infection of the mother is common. Am J Obstet Gynecol (1997) 1.11
Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer. Prostate (1999) 1.11
Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium. Acta Med Scand (1980) 1.11
p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis. J Clin Pathol (2003) 1.09
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.08
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin Oncol (1996) 1.08
Human papilloma virus (HPV) infections related to cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma of the uterine cervix. Ann Clin Res (1985) 1.08
p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol (2000) 1.07
Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol (2001) 1.07
Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer. Br J Cancer (1999) 1.07
Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation. J Clin Pathol (2001) 1.06
Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells. Pancreas (2001) 1.05
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Expression of hyaluronan in benign and malignant breast lesions. Int J Cancer (1997) 1.04
Dose and time dependency of inflammatory responses in the mouse lung to urban air coarse, fine, and ultrafine particles from six European cities. Inhal Toxicol (2007) 1.04
Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables. Cancer Genet Cytogenet (2000) 1.03
Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol (2000) 1.02
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol (1995) 1.02
Detection of human papillomavirus DNA in anogenital condylomata in men using in situ DNA hybridisation applied to paraffin sections. Genitourin Med (1987) 1.01
Human papillomavirus (HPV) involvement in squamous cell lesions of the oral cavity. Proc Finn Dent Soc (1983) 1.01
Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.00
Inducible nitric oxide synthase (iNOS) expression and its prognostic value in prostate cancer. Anticancer Res (2001) 1.00
Reduced expression of alpha catenin is associated with poor prognosis in colorectal carcinoma. J Clin Pathol (1999) 0.99
Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis. Scand J Gastroenterol (1998) 0.99
Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer. J Cancer Res Clin Oncol (1995) 0.98
Low serum vitamin D metabolites in women with rheumatoid arthritis. Scand J Rheumatol (1993) 0.98
Current concepts of human papillomavirus infections in the genital tract and their relationship to intraepithelial neoplasia and squamous cell carcinoma. Obstet Gynecol Surv (1984) 0.98
Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma. Am J Pathol (2000) 0.98
Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration (1979) 0.97
Lack of type-specific concordance between human papillomavirus (HPV) serology and HPV DNA detection in the uterine cervix and oral mucosa. J Gen Virol (2011) 0.97
Expression of cyclins A and D and p21(waf1/cip1) proteins in renal cell cancer and their relation to clinicopathological variables and patient survival. Br J Cancer (1999) 0.97
p21/WAF1 expression as related to p53, cell proliferation and prognosis in epithelial ovarian cancer. Br J Cancer (1999) 0.97
Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur J Cancer (1995) 0.96
Thenar muscle blood flow and bone mineral in the forearms of lumberjacks. Br J Ind Med (1975) 0.96
Anal condylomas in men. 1. Histopathological and virological assessment. Genitourin Med (1989) 0.95
p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. Br J Cancer (1999) 0.95
Bone mineral in patients with osteoarthrosis of the hip. Acta Orthop Scand (1975) 0.95